Nonetheless, since AR signaling is critical to PCa development and progression to the lethal stage of castration-resistant PCa (CRPC) (13), studies from us and others highly suggest that targeting LSD1 may be a potential treatment strategy for PCa and particularly CRPC, where AR signaling is commonly restored. This evidence concerns the gene KDM1A and posterior cortical atrophy.